Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with malignancies-Reference-Cited by-同舟云学术

Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with malignancies

Published:2015-10-19 Issue:5 Volume:173 Page:1224-1231
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Wu J.¹²,Lee Y.Y.¹²,Su S.C.¹²,Wu T.S.²³,Kao K.C.²⁴,Huang C.C.²⁴,Chang W.C.²⁵,Yang C.H.¹²,Chung W.H.¹²

Affiliation:

1. Department of Dermatology; Drug Hypersensitivity Clinical and Research Center; Chang Gung Memorial Hospital; Keelung Taipei and Linkou 33305 Taiwan

2. College of Medicine; Chang Gung University; Taoyuan 33302 Taiwan

3. Department of Infectious Disease; Chang Gung Memorial Hospital; Keelung Taipei and Linkou 33305 Taiwan

4. Department of Thoracic Medicine; Chang Gung Memorial Hospital; Keelung Taipei and Linkou 33305 Taiwan

5. Department of Hematology-Oncology; Chang Gung Memorial Hospital; Keelung Taipei and Linkou 33305 Taiwan

Funder

National Science Council

Chang Gung Memorial Hospital, Linkou

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.14052/fullpdf

Reference32 articles.

1. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis;Roujeau;N Engl J Med,1995

2. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis;Bastuji-Garin;J Invest Dermatol,2000

3. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis;Chung;Nat Med,2008

4. Severe adverse cutaneous reactions to drugs;Roujeau;N Engl J Med,1994

5. A multicenter review of toxic epidermal necrolysis treated in U.S. burn centers at the end of the twentieth century;Palmieri;J Burn Care Rehabil,2002

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stevens-Johnson syndrome and toxic epidermal necrolysis associated with immune checkpoint inhibitors: a systematic review;Frontiers in Immunology;2024-07-12

2. Methotrexate might become the sole treatment option for leukemia following the occurrence of Stevens–Johnson syndrome;Allergologia et Immunopathologia;2024-07-01

3. YOĞUN BAKIMDA TOKSİK EPİDERMAL NEKROLİZLİ HASTA BAKIMI;Yoğun Bakım Hemşireliği Dergisi;2023-12-31

4. Development and Validation of a Novel Score to Predict Mortality in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: CRISTEN;The Journal of Allergy and Clinical Immunology: In Practice;2023-10

5. Does A History of Malignancy Lead to Worse Outcomes in a Single-center Burn Unit?;Journal of Burn Care & Research;2023-01-06